A. Membership:
| Name | Role | Department/Institution | Term |
|---|---|---|---|
| Joaquin Ortega | Director |
Anatomy & Cell Biology/麻豆社 |
04-2022/03-2027 |
| Hojatollah Vali |
Director Emeritus |
Anatomy & Cell Biology/麻豆社 |
Unlimited |
|
Audrey Moores |
Associate Director |
Chemistry/麻豆社 | 04-2022/03-2027 |
| S Kelly Sears | Research Manager/Staff Scientist | FEMR/麻豆社 | Unlimited |
| Alba Guarne | Member | Biochemistry/麻豆社 | 04-2022/03-2027 |
| Timothy Kennedy | Member | Montreal Neurological Institute/麻豆社 | 10-2025/10-2027 |
| Shreya Krishnan | Member (Trainee) | Biochemistry/麻豆社 | 10-2022/09-2027 |
| Marc McKee | Member | Dentistry/麻豆社 | 03-2021/02-2026 |
| Natalie Reznikov | Member | Bioengineering/麻豆社 | 04-2022/03-2027 |
| Alfredo Ribeiro-da-Silva | Member | Pharmacology/麻豆社 | 10-2022/09-2027 |
| Natalie Zeytuni | Member | Anatomy & Cell Biology/麻豆社 | 04-2022/03-2027 |
B. Mandate:
The BoA establishes the scientific direction of the FEMR, proposes improvements to the infrastructure through CFI and other funding bodies, and manages the facility (including proposing instrument and user fees) and staffing. It approves the annual budget. It also ensures the research infrastructure and resources of the FEMR are allocated to stakeholders according to their needs, scientific priorities, and financial support to the FEMR. The BoA also approves major training activities (e.g., workshops, summer school). The BoA prepares the annual report.
C. Meeting frequency:
Biannually.
D. Relationship to other committees:
Reports to the Board of Directors (BoD) on an annual basis and to the International Scientific Advisory Committee (ISAC) every three years.